Pharmacists' perspectives of biosimilars: a systematic review
Abstract Background and Objective While biosimilars are less expensive than their
originator biologics, various factors are known to impede their uptake in clinical practice …
originator biologics, various factors are known to impede their uptake in clinical practice …
[HTML][HTML] Pharmacists' knowledge, familiarity, and attitudes towards biosimilar drugs among practicing Jordanian pharmacists: A cross sectional study
Objective Biosimilar (BSM) drugs are currently being manufactured and dispensed in
several pharmaceutical markets worldwide, including Jordan. They are clinically similar to …
several pharmaceutical markets worldwide, including Jordan. They are clinically similar to …
[HTML][HTML] Biosimilars: From Production to Patient
M Sheridan, M Massich, N Ashourian - Journal of Infusion Nursing, 2024 - journals.lww.com
Biologic drugs are large, complex molecules produced through biotechnology. A biosimilar
is a biologic product that is highly similar to an already approved biologic (reference …
is a biologic product that is highly similar to an already approved biologic (reference …